Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal Pain in Cancer Patients,

Not Applicable

Recruiting

• Conditions: Perineal Pain

• Registration Number: NCT06008899
• Lead Sponsor: Assiut University

Brief Summary

Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-08-17
• Study First Submitted QC: 2023-08-23
• Study First Posted: 2023-08-24
• Study Start: 2023-08-25
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-06
• Last Update Posted: 2024-08-07
• Primary Completion: 2024-12
• Study Completion: 2025-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• American Society of Anesthesiology physical status of I or III (ASA), of both sex
• cancer-related anal or perineal pain

Exclusion Criteria

• coagulopathies
• allergies to the contrast dye
• patients with moderate or significant cardiac/respiratory disease or hepatic

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
visual analog scale (VAS) score 4 weeks post-intervention	8 weeks	Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks

Trial Locations

Locations (1)

South Egypt Cancer instIitute; 🇪🇬 Assuit, Egypt